Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature

Summary

Many preanalytical variables affect the results of coagulation assays. A possible way to control some of them would be to accept blood specimens shipped in the original collection tube. The aim of our study was to investigate the stability of coagulation assays in citrated whole blood transported at ambient temperature for up to two days after specimen collection. Blood samples from 59 patients who attended our haematology outpatient ward for thrombophilia screening were transported at ambient temperature (outdoor during the day, indoor overnight) for following periods of time: <1 hour, 4–6, 8–12, 24–28 and 48–52 hours prior to centrifugation and plasma-freezing. The following coagulation tests were performed: PT, aPTT, fibrinogen, FII:C, FV:C, FVII:C, FVIII:C, FIX:C, FX:C, FXI:C,VWF:RCo,VWF:Ag, AT, PC activity, total and free PS antigen, modified APC-sensitivity-ratio, thrombin-antithrombin-complex and D-dimer. Clinically significant changes, defined as a percentage change of more than 10% from the initial value, were observed for FV:C, FVIII:C and total PS antigen starting at 24–28 hours, and for PT, aPTT and FVII:C at 48–52 hours. No statistically significant differences were seen for fibrinogen, antithrombin, or thrombin-antithrombin complexes (Friedman repeated measures analysis of variance).The present data suggest that the use of whole blood samples transported at ambient temperature may be an acceptable means of delivering specimens for coagulation analysis. With the exception of factorV andVIII coagulant activity, and total PS antigen all investigated parameters can be measured 24–28 hours after specimen collection without observing clinically relevant changes.

Keywords

Coagulation factors - thrombophilia - laboratory - preanalytic

• References

• 1 Arkin CF, Adcock DM, Ernst DJ. et al. Collection, transport, and processing of blood samples for testing plasma-based coagulation assays. Approved guideline – Fourth edition.. Clinical and Laboratory Standards Institute; 2003. document H21-A4.
• 2 Adcock D, Kressin D, Marlar RA. The effect of time and temperature variables on routine coagulation tests. Blood Coagul Fibrinolysis 1998; 9: 463-470.
• 3 Rao LV, Okorodudu AO, Petersen JR. et al. Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. Clin Chim Acta 2000; 300: 13-21.
• 4 Luddington R, Peters J, Baker P. et al. The effect of delayed analysis or freeze-thawing on the measurement of natural anticoagulants, resistance to activated protein C and markers of activation of the haemostatic system. Thromb Res 1997; 87: 577-581.
• 5 Caliezi C, Reber G, Lammle B. et al. Agreement of D-dimer results measured by a rapid ELISA (VIDAS) before and after storage during 24h or transportation of the original whole blood samples. Thromb Haemost 2000; 83: 177-178.
• 6 Poller L. Screening INR deviation of local prothrombin time systems. J Clin Pathol 1998; 51: 356-359.
• 7 Hillarp A, Egberg N, Nordin G. et al. Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme. Thromb Haemost 2004; 91: 300-307.
• 8 van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ. et al. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005; 51: 561-568.
• 9 Brigden ML, Graydon C, McLeod B. et al. Prothrombin time determination. The lack of need for a discard tube and 24-hour stability. Am J Clin Pathol 1997; 108: 422-426.
• 10 Eschwege V, Trillard M, Robert A. Overestimation of plasma level of factor V coagulant activity due to unrecognised preanalytical coagulation. Thromb Haemost 2004; 91: 827-828.
• 11 Stein PD, Hull RD, Patel KC. et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004; 140: 589-602.
• 12 Palareti G, Legnani C, Cosmi B. et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002; 87: 7-12.
• 13 Palareti G, Legnani C, Cosmi B. et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-318.
• 14 Kyrle PA, Minar E, Hirschl M. et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343: 457-462.
• 15 Meijer P, Kluft C, Haverkate F. et al. The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation. J Thromb Haemost 2003; 1: 748-753.